Drug name - Kerendia
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8436180 | BAYER HLTHCARE | Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof |
Apr, 2029
(6 years from now) | |
| CN101641352A | BAYER HLTHCARE | Substituted 4-Aryl-1,4-Dihydro-1,6-Naphthyridinamides And Use Thereof |
Feb, 2028
(5 years from now) | |
| CN101641352B | BAYER HLTHCARE | Substituted 4-Aryl-1,4-Dihydro-1,6-Naphthyridinamides And Use Thereof |
Feb, 2028
(5 years from now) | |
| IN200904992P1 | BAYER HLTHCARE | Substituted 4-Aryl-1,4-Dihydro-1,6-Naphthyridine Amides And Their Use |
Feb, 2028
(5 years from now) | |
| IN300241B | BAYER HLTHCARE | Substituted 4-Aryl-1, 4-Dihydro-1, 6-Naphthyridine Compound Of Formula (I) |
Feb, 2028
(5 years from now) | |
| EP2132206B1 | BAYER HLTHCARE | Substituted 4-Aryl-1,4-Dihydro-1,6-Naphthyridinamides And Use Thereof |
Feb, 2028
(5 years from now) | |
| EP2132206A2 | BAYER HLTHCARE | Substituted 4-Aryl-1,4-Dihydro-1,6-Naphthyridinamides And Use Thereof |
Feb, 2028
(5 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 10MG | TABLET;ORAL | Prescription |
| 20MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.